Undervalued and novel roles of heterogeneous nuclear ribonucleoproteins in autoimmune diseases: Resurgence as potential biomarkers and targets
- PMID: 37365887
- DOI: 10.1002/wrna.1806
Undervalued and novel roles of heterogeneous nuclear ribonucleoproteins in autoimmune diseases: Resurgence as potential biomarkers and targets
Abstract
Autoimmune diseases are mainly characterized by the abnormal autoreactivity due to the loss of tolerance to specific autoantigens, though multiple pathways associated with the homeostasis of immune responses are involved in initiating or aggravating the conditions. The heterogeneous nuclear ribonucleoproteins (hnRNPs) are a major category of RNA-binding proteins ubiquitously expressed in a multitude of cells and have attracted great attentions especially with their distinctive roles in nucleic acid metabolisms and the pathogenesis in diseases like neurodegenerative disorders and cancers. Nevertheless, the interplay between hnRNPs and autoimmune disorders has not been fully elucidated. Virtually various family members of hnRNPs are increasingly identified as immune players and are pertinent to all kinds of immune-related processes including immune system development and innate or adaptive immune responses. Specifically, hnRNPs have been extensively recognized as autoantigens within and even beyond a myriad of autoimmune diseases, yet their diagnostic and prognostic values are seemingly underestimated. Molecular mimicry, epitope spreading and bystander activation may represent major putative mechanisms underlying the presence of autoantibodies to hnRNPs. Besides, hnRNPs play critical parts in regulating linchpin genes expressions that control genetic susceptibility, disease-linked functional pathways, or immune responses by interacting with other components particularly like microRNAs and long non-coding RNAs, thereby contributing to inflammation and autoimmunity as well as specific disease phenotypes. Therefore, comprehensive unraveling of the roles of hnRNPs is conducive to establishing potential biomarkers and developing better intervention strategies by targeting these hnRNPs in the corresponding disorders. This article is categorized under: RNA in Disease and Development > RNA in Disease RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications.
Keywords: RNA-binding protein; autoantigen; autoimmune disorder; gene expression regulation; heterogeneous nuclear ribonucleoprotein.
© 2023 Wiley Periodicals LLC.
Similar articles
-
Heterogeneous nuclear ribonucleoproteins (hnRNPs): an emerging family of autoantigens in rheumatic diseases.Clin Exp Rheumatol. 1998 May-Jun;16(3):317-26. Clin Exp Rheumatol. 1998. PMID: 9631758 Review.
-
Research Progress on the Structural and Functional Roles of hnRNPs in Muscle Development.Biomolecules. 2023 Sep 22;13(10):1434. doi: 10.3390/biom13101434. Biomolecules. 2023. PMID: 37892116 Free PMC article. Review.
-
Heterogeneous nuclear ribonucleoproteins (hnRNPs) in cellular processes: Focus on hnRNP E1's multifunctional regulatory roles.RNA. 2010 Aug;16(8):1449-62. doi: 10.1261/rna.2254110. Epub 2010 Jun 28. RNA. 2010. PMID: 20584894 Free PMC article. Review.
-
Multiple functions of heterogeneous nuclear ribonucleoproteins in the positive single-stranded RNA virus life cycle.Front Immunol. 2022 Sep 2;13:989298. doi: 10.3389/fimmu.2022.989298. eCollection 2022. Front Immunol. 2022. PMID: 36119073 Free PMC article. Review.
-
The role of interactions of long non-coding RNAs and heterogeneous nuclear ribonucleoproteins in regulating cellular functions.Biochem J. 2017 Aug 11;474(17):2925-2935. doi: 10.1042/BCJ20170280. Biochem J. 2017. PMID: 28801479 Free PMC article. Review.
Cited by
-
hnRNPH1: A Multifaceted Regulator in RNA Processing and Disease Pathogenesis.Int J Mol Sci. 2025 May 28;26(11):5159. doi: 10.3390/ijms26115159. Int J Mol Sci. 2025. PMID: 40507967 Free PMC article. Review.
References
REFERENCES
-
- Abbadi, D., Yang, M., Chenette, D. M., Andrews, J. J., & Schneider, R. J. (2019). Muscle development and regeneration controlled by AUF1-mediated stage-specific degradation of fate-determining checkpoint mRNAs. Proceedings of the National Academy of Sciences of the United States of America, 116(23), 11285-11290. https://doi.org/10.1073/pnas.1901165116
-
- Acevedo, M. J., Caro-Oleas, J. L., Álvarez-Márquez, A. J., Sobrino, J. M., Lage-Gallé, E., Aguilera, I., & Núñez-Roldán, A. (2011). Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation, 30(9), 1051-1059. https://doi.org/10.1016/j.healun.2011.02.014
-
- Alam, J., Kim, Y. C., & Choi, Y. (2014). Potential role of bacterial infection in autoimmune diseases: A new aspect of molecular mimicry. Immune Network, 14(1), 7-13. https://doi.org/10.4110/in.2014.14.1.7
-
- Alarcón, C. R., Goodarzi, H., Lee, H., Liu, X., Tavazoie, S., & Tavazoie, S. F. (2015). HNRNPA2B1 is a mediator of m(6)A-dependent nuclear RNA processing events. Cell, 162(6), 1299-1308. https://doi.org/10.1016/j.cell.2015.08.011
-
- An, Y., Zheng, Z., Zhang, X., Cho, S. B., Kim, D. Y., Choi, M. J., & Bang, D. (2017). Cilostazol inhibits the expression of hnRNP A2/B1 and cytokines in human dermal microvascular endothelial cells. Clinical and Experimental Rheumatology, 35, 60-66.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical